Review



crossmabs roche wo2011117329  (Roche)


Bioz Verified Symbol Roche is a verified supplier
Bioz Manufacturer Symbol Roche manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Roche crossmabs roche wo2011117329
    Crossmabs Roche Wo2011117329, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmabs roche wo2011117329/product/Roche
    Average 86 stars, based on 1 article reviews
    crossmabs roche wo2011117329 - by Bioz Stars, 2026-04
    86/100 stars

    Images



    Similar Products

    crossmab  (Brinkmann Instruments)
    90
    Brinkmann Instruments crossmab
    Crossmab, supplied by Brinkmann Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmab/product/Brinkmann Instruments
    Average 90 stars, based on 1 article reviews
    crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    crossmab  (WuXi Biologics)
    90
    WuXi Biologics crossmab
    Crossmab, supplied by WuXi Biologics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmab/product/WuXi Biologics
    Average 90 stars, based on 1 article reviews
    crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    crossmabs roche wo2011117329  (Roche)
    86
    Roche crossmabs roche wo2011117329
    Crossmabs Roche Wo2011117329, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmabs roche wo2011117329/product/Roche
    Average 86 stars, based on 1 article reviews
    crossmabs roche wo2011117329 - by Bioz Stars, 2026-04
    86/100 stars
    		  Buy from Supplier
    crossmab antibody  (Brinkmann Instruments)
    90
    Brinkmann Instruments crossmab antibody
    Crossmab Antibody, supplied by Brinkmann Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmab antibody/product/Brinkmann Instruments
    Average 90 stars, based on 1 article reviews
    crossmab antibody - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    crossmab  (Thermo Fisher)
    90
    Thermo Fisher crossmab
    Crossmab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/crossmab/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    20 μg crossmab  (Thermo Fisher)
    90
    Thermo Fisher 20 μg crossmab
    SE-HPLC chromatogram of a Complex Therapeutic 2 + 1 bsAb. During SE-HPLC of the 2 + 1 <t>CrossMAb</t> after protein A purification, HMW by-products were observed at low abundancy, representing less than 1% of the total area under the curve (AUC). The hypothesized by-products are indicated on the peaks representing HMW variants. Indicated fractions were collected for further analysis.
    20 μg Crossmab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/20 μg crossmab/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    20 μg crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    zenocutuzumab crossmab  (Merus Labs)
    90
    Merus Labs zenocutuzumab crossmab
    Current clinical trials of bsAbs based on mechanism of action in solid malignancies.
    Zenocutuzumab Crossmab, supplied by Merus Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zenocutuzumab crossmab/product/Merus Labs
    Average 90 stars, based on 1 article reviews
    zenocutuzumab crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    zanidatamab crossmab  (Zymeworks)
    90
    Zymeworks zanidatamab crossmab
    Current clinical trials of bsAbs based on mechanism of action in solid malignancies.
    Zanidatamab Crossmab, supplied by Zymeworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/zanidatamab crossmab/product/Zymeworks
    Average 90 stars, based on 1 article reviews
    zanidatamab crossmab - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    SE-HPLC chromatogram of a Complex Therapeutic 2 + 1 bsAb. During SE-HPLC of the 2 + 1 CrossMAb after protein A purification, HMW by-products were observed at low abundancy, representing less than 1% of the total area under the curve (AUC). The hypothesized by-products are indicated on the peaks representing HMW variants. Indicated fractions were collected for further analysis.

    Journal: mAbs

    Article Title: Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody

    doi: 10.1080/19420862.2023.2175312

    Figure Lengend Snippet: SE-HPLC chromatogram of a Complex Therapeutic 2 + 1 bsAb. During SE-HPLC of the 2 + 1 CrossMAb after protein A purification, HMW by-products were observed at low abundancy, representing less than 1% of the total area under the curve (AUC). The hypothesized by-products are indicated on the peaks representing HMW variants. Indicated fractions were collected for further analysis.

    Article Snippet: Sample injection amounts of 20 μg CrossMAb were used and data acquisition was controlled by Chromeleon software (Thermo Fisher Scientific).

    Techniques: Purification

    Gene reporter assays measuring variant potency. Dose-response curves show the binding of CD3 Fabs to CD3e expressed on JURKAT cells, meant to simulate downstream signaling. The tetravalent control has the highest potency compared to the 2 + 1 CrossMAb control. The HMW1 fraction, thought to contain the tetravalent variant, shows a remarkably similar response as the product control. The dimer (HMW2 fraction) shows a substantially reduced potency.

    Journal: mAbs

    Article Title: Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody

    doi: 10.1080/19420862.2023.2175312

    Figure Lengend Snippet: Gene reporter assays measuring variant potency. Dose-response curves show the binding of CD3 Fabs to CD3e expressed on JURKAT cells, meant to simulate downstream signaling. The tetravalent control has the highest potency compared to the 2 + 1 CrossMAb control. The HMW1 fraction, thought to contain the tetravalent variant, shows a remarkably similar response as the product control. The dimer (HMW2 fraction) shows a substantially reduced potency.

    Article Snippet: Sample injection amounts of 20 μg CrossMAb were used and data acquisition was controlled by Chromeleon software (Thermo Fisher Scientific).

    Techniques: Variant Assay, Binding Assay

    SEC-nMS Analysis of the 2 + 1 CrossMAb Product. The mass of the analyzed product is 197,037.9 Da (cyan diamond). An inset shows the charge deconvoluted spectrum from 6000 to 8500 m/z. Gains and losses of Hex(1) and GlcNAc(1) are annotated by blue and green bars. A small portion of dimer is observed, likely formed through non-covalent interactions during storage.

    Journal: mAbs

    Article Title: Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody

    doi: 10.1080/19420862.2023.2175312

    Figure Lengend Snippet: SEC-nMS Analysis of the 2 + 1 CrossMAb Product. The mass of the analyzed product is 197,037.9 Da (cyan diamond). An inset shows the charge deconvoluted spectrum from 6000 to 8500 m/z. Gains and losses of Hex(1) and GlcNAc(1) are annotated by blue and green bars. A small portion of dimer is observed, likely formed through non-covalent interactions during storage.

    Article Snippet: Sample injection amounts of 20 μg CrossMAb were used and data acquisition was controlled by Chromeleon software (Thermo Fisher Scientific).

    Techniques:

    Current clinical trials of bsAbs based on mechanism of action in solid malignancies.

    Journal: Pharmaceutics

    Article Title: Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors

    doi: 10.3390/pharmaceutics14112442

    Figure Lengend Snippet: Current clinical trials of bsAbs based on mechanism of action in solid malignancies.

    Article Snippet: Zenocutuzumab , CrossMab , HER2/HER3 , Solid tumors , 1/2 , NCT02912949 , R , , Merus N.V. (Utrecht, The Netherlands).

    Techniques: Clinical Proteomics

    Current clinical trials of bsAbs based on mechanism of action in solid malignancies.

    Journal: Pharmaceutics

    Article Title: Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors

    doi: 10.3390/pharmaceutics14112442

    Figure Lengend Snippet: Current clinical trials of bsAbs based on mechanism of action in solid malignancies.

    Article Snippet: Zanidatamab , CrossMab , HER2 , Solid tumors , 1 , NCT02892123 , ANR , , Zymeworks Inc./BeiGene, Ltd. (Vancouver, BC, Canada).

    Techniques: Clinical Proteomics